HRP970473B1 - 6-0-substituted ketolides having antibacterial activity - Google Patents

6-0-substituted ketolides having antibacterial activity

Info

Publication number
HRP970473B1
HRP970473B1 HR970473A HRP970473A HRP970473B1 HR P970473 B1 HRP970473 B1 HR P970473B1 HR 970473 A HR970473 A HR 970473A HR P970473 A HRP970473 A HR P970473A HR P970473 B1 HRP970473 B1 HR P970473B1
Authority
HR
Croatia
Prior art keywords
substituted
alkyl
aryl
heteroaryl
group
Prior art date
Application number
HR970473A
Other languages
English (en)
Croatian (hr)
Inventor
Sun Or Yat
T. Chu Daniel
Ma Zhenkun
J. Plattner Jacob
F. Clark Richard
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27107953&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP970473(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/888,350 external-priority patent/US5866549A/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of HRP970473A2 publication Critical patent/HRP970473A2/hr
Publication of HRP970473B1 publication Critical patent/HRP970473B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cephalosporin Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR970473A 1996-09-04 1997-09-03 6-0-substituted ketolides having antibacterial activity HRP970473B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70777696A 1996-09-04 1996-09-04
US08/888,350 US5866549A (en) 1996-09-04 1997-07-03 6-O-substituted ketolides having antibacterial activity

Publications (2)

Publication Number Publication Date
HRP970473A2 HRP970473A2 (en) 1998-08-31
HRP970473B1 true HRP970473B1 (en) 2007-02-28

Family

ID=27107953

Family Applications (5)

Application Number Title Priority Date Filing Date
HR970473A HRP970473B1 (en) 1996-09-04 1997-09-03 6-0-substituted ketolides having antibacterial activity
HRP20060276AA HRP20060276B1 (hr) 1996-09-04 2006-08-11 6-0-supstituirani ketolidi antibakterijskog djelovanja
HRP20060275AA HRP20060275B1 (hr) 1996-09-04 2006-08-11 6-0-supstituirani ketolidi antibakterijskog djelovanja
HRP20060278AA HRP20060278B1 (hr) 1996-09-04 2006-08-11 6-0-supstituirani ketolidi antibakterijskog djelovanja
HRP20060277AA HRP20060277B1 (hr) 1996-09-04 2006-08-11 6-0-supstituirani ketolidi antibakterijskog djelovanja

Family Applications After (4)

Application Number Title Priority Date Filing Date
HRP20060276AA HRP20060276B1 (hr) 1996-09-04 2006-08-11 6-0-supstituirani ketolidi antibakterijskog djelovanja
HRP20060275AA HRP20060275B1 (hr) 1996-09-04 2006-08-11 6-0-supstituirani ketolidi antibakterijskog djelovanja
HRP20060278AA HRP20060278B1 (hr) 1996-09-04 2006-08-11 6-0-supstituirani ketolidi antibakterijskog djelovanja
HRP20060277AA HRP20060277B1 (hr) 1996-09-04 2006-08-11 6-0-supstituirani ketolidi antibakterijskog djelovanja

Country Status (28)

Country Link
US (4) US6147197A (de)
EP (5) EP1291350B1 (de)
JP (1) JP4597274B2 (de)
KR (5) KR100576988B1 (de)
CN (4) CN1273475C (de)
AT (5) ATE299508T1 (de)
BG (1) BG63547B1 (de)
BR (1) BR9711661A (de)
CA (1) CA2263972C (de)
CZ (1) CZ300106B6 (de)
DE (5) DE69733369T2 (de)
DK (5) DK1291351T3 (de)
ES (5) ES2242812T3 (de)
HK (1) HK1021537A1 (de)
HR (5) HRP970473B1 (de)
HU (1) HU230166B1 (de)
ID (1) ID19406A (de)
IL (1) IL128681A0 (de)
NO (1) NO314230B1 (de)
NZ (1) NZ334274A (de)
PL (1) PL188173B1 (de)
PT (5) PT1291352E (de)
RO (1) RO121473B1 (de)
RU (1) RU2192427C2 (de)
SI (1) SI20023B (de)
SK (5) SK285533B6 (de)
TR (1) TR199901127T2 (de)
WO (1) WO1998009978A1 (de)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495348B1 (en) 1993-10-07 2002-12-17 Regents Of The University Of Minnesota Mitomycin biosynthetic gene cluster
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
ES2199524T3 (es) 1998-04-24 2004-02-16 Pfizer Products Inc. Derivados 9a,11b-deshidro de 9-oxima-3-ceto-6-o-metileritromicina.
US6265202B1 (en) 1998-06-26 2001-07-24 Regents Of The University Of Minnesota DNA encoding methymycin and pikromycin
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JP4573925B2 (ja) 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2785612A1 (fr) * 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
BR9914998A (pt) 1998-11-03 2001-07-10 Pfizer Prod Inc Antibióticos macrólidos
ES2222189T3 (es) * 1999-03-15 2005-02-01 Abbott Laboratories Macrolidos sustituidos en 6-o con una actividad antibacteriana.
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
JP2003523938A (ja) 1999-04-16 2003-08-12 コーサン バイオサイエンシーズ， インコーポレイテッド マクロライド系抗感染剤
WO2000075156A1 (en) * 1999-06-07 2000-12-14 Abbott Laboratories 6-o-carbamate ketolide derivatives
US6420535B1 (en) * 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6417366B2 (en) * 1999-06-24 2002-07-09 Abbott Laboratories Preparation of quinoline-substituted carbonate and carbamate derivatives
EP1101769A3 (de) 1999-11-18 2001-10-24 Pfizer Products Inc. Stickstoff-enthaltend Erythromycin-Derivate
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
AU2002316550A1 (en) * 2001-07-03 2003-01-21 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
CA2460947A1 (en) 2001-09-17 2003-03-27 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
US6673774B2 (en) * 2001-12-03 2004-01-06 Enanta Pharmaceuticals, Inc. 11-O-substituted macrolides and their descladinose derivatives
MXPA04005424A (es) 2001-12-05 2005-06-20 Johnson & Johnson Derivados de 6-o-aciletolido de eritromicina utiles como antibacterianos.
US6831068B2 (en) * 2002-02-13 2004-12-14 Abbott Laboratories Macrolide antibacterial compounds
US20030162729A1 (en) * 2002-02-13 2003-08-28 Zhenkun Ma Macrolides with activity against methicillin-resistant staphylococcus aureus
CA2476223A1 (en) * 2002-02-13 2003-08-21 Abbott Laboratories Macrolide antibacterial compounds
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
US6995143B2 (en) 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
CN1671726A (zh) 2002-05-31 2005-09-21 詹森药业有限公司 3－脱克拉定糖基－6－o－氨基甲酰基和6－o－烷氧基羰基大环内酯抗菌药
WO2004078771A1 (ja) * 2003-03-07 2004-09-16 Taisho Pharmaceutical Co., Ltd. ２－フルオロ－６－ｏ－置換ケトライド誘導体
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
US7163924B2 (en) * 2003-04-25 2007-01-16 Chiron Corporation Ketolide derivatives
US6790835B1 (en) * 2003-06-05 2004-09-14 Enanta Pharmaceuticals, Inc. Bicyclic macrolide derivatives
US20040254126A1 (en) * 2003-06-05 2004-12-16 Yao-Ling Qiu 11-12 Bicyclic erythromycin derivatives
WO2005028493A1 (en) * 2003-09-12 2005-03-31 Chiron Corporation Antimicrobial derivatives
GB0327720D0 (en) 2003-11-28 2003-12-31 Biotica Tech Ltd Erythromycins and process for their preparation
WO2005067564A2 (en) * 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. 6-11 bicyclic erythromycin derivatives
WO2005070113A2 (en) * 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
FR2874922A1 (fr) * 2004-07-30 2006-03-10 Palumed Sa Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
AU2005279050A1 (en) * 2004-07-30 2006-03-09 Centre National De La Recherche Scientifique (Cnrs) Hybrid molecules QA where Q is an aminoquinoline and A is an antibiotic residue, and the synthesis and uses thereof as antibacterial agents
WO2006065743A2 (en) * 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. Tetracylic bicyclolides
ES2339871T3 (es) 2004-12-21 2010-05-26 Pfizer Products Inc. Macrolidos.
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060252710A1 (en) * 2005-05-04 2006-11-09 Guoqiang Wang 6-11 Bridged oxime erythromycin derivatives
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
JP5015016B2 (ja) 2006-02-07 2012-08-29 大正製薬株式会社 １０ａ−アザライド化合物
KR20090042971A (ko) 2006-08-24 2009-05-04 욱크하르트 리서치 센터 항미생물 활성을 갖는 신규한 마크로라이드 및 케토라이드
EP2177526A4 (de) 2007-08-06 2012-08-22 Taisho Pharmaceutical Co Ltd An position 10a und position 12 vernetzte 10a-azalidverbindung
KR101223158B1 (ko) * 2007-09-17 2013-01-17 이난타 파마슈티칼스, 인코포레이티드 6,11-다리걸친 바이아릴 매크로라이드
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
CN101917850B (zh) * 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
JPWO2009139181A1 (ja) 2008-05-15 2011-09-15 大正製薬株式会社 ４員環構造を有する１０ａ−アザライド化合物
WO2010048601A1 (en) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US8541420B2 (en) 2009-05-27 2013-09-24 Wockhardt Ltd. Ketolide compounds having antimicrobial activity
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (de) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Verfahren zur behandlung von malaria, tuberkulose und mac-erkrankungen
AU2011232627B2 (en) 2010-03-22 2016-03-17 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
RU2608390C2 (ru) 2010-05-20 2017-01-18 Семпра Фармасьютикалз, Инк. Способы получения макролидов и кетолидов, и промежуточных соединений для их получения
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
EP2673285B1 (de) 2010-12-09 2017-07-19 Wockhardt Limited Ketolidverbindungen
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
JP5718488B2 (ja) 2011-03-01 2015-05-13 ウォックハート リミテッド ケトライド中間体の調製方法
CA2830861C (en) 2011-03-22 2017-01-24 Wockhardt Limited Process for preparation of ketolide compounds
CN102766089A (zh) * 2011-05-06 2012-11-07 上海医药工业研究院 3-(3-喹啉基)-2-丙烯-1-卤代物及其制备方法
CN102766181A (zh) * 2011-05-06 2012-11-07 上海医药工业研究院 6-o-取代的红霉素衍生物的制备方法
NZ700182A (en) * 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 Ｃ−４”位置換マクロライド誘導体を含有する医薬
GB201217310D0 (en) 2012-09-27 2012-11-14 C10 Pharma As Compounds
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
JP6675973B2 (ja) 2013-03-15 2020-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド抗菌薬を調製するための集束的な方法
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
EP3522896A4 (de) * 2016-10-04 2020-06-17 Biopharmati SA Ketolide mit antibakterieller wirkung
US11420995B2 (en) 2017-03-03 2022-08-23 Synovo Gmbh Anti-infective and anti-inflammatory compounds
CN109942653B (zh) * 2019-02-27 2021-06-25 北京理工大学 一种红霉素衍生物及其制备方法
KR20220108102A (ko) * 2019-12-02 2022-08-02 알리퀀텀알엑스 인코포레이티드 질환의 치료를 위한 세트로마이신의 염 및 다형체, 세트로마이신의 염 및 다형체
CN113817008B (zh) * 2021-07-15 2023-05-23 湖州师范学院 新型琥珀酰基十六元大环内酯的制备方法及用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
CA2094060A1 (en) * 1990-10-15 1992-04-16 Toshifumi Asaka 2'-position modified compound of erythromycin or its derivative
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
CA2096969C (en) * 1990-11-28 2000-11-21 Masato Kashimura 6-0-methylerythromycin a derivatives
WO1993013663A1 (en) * 1992-01-17 1993-07-22 Abbott Laboratories Method of directing biosynthesis of specific polyketides
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
CA2093303C (en) * 1992-04-09 1998-11-24 Abraham Araya Aluminosilicates
WO1993021199A1 (en) * 1992-04-22 1993-10-28 Taisho Pharmaceutical Co., Ltd. 5-o-desosaminylerythronolide a derivative
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2713226B1 (fr) * 1993-12-03 1996-01-05 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2732684B1 (fr) * 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2738571B1 (fr) * 1995-09-11 1997-10-17 Roussel Uclaf Nouveaux derives de la 5-0-desosaminyl 6-0-methyl- erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
PT876388E (pt) * 1995-11-08 2004-07-30 Abbott Lab Derivados de eritromicina triciclica
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
WO1998018808A1 (en) * 1996-10-31 1998-05-07 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6171807B1 (en) * 1996-11-13 2001-01-09 Associates Of Cape Cod, Inc. Detection and quantitation of endotoxin by fluorescence polarization

Also Published As

Publication number Publication date
NO314230B1 (no) 2003-02-17
BG103292A (en) 1999-12-30
JP4597274B2 (ja) 2010-12-15
DE69733369D1 (de) 2005-06-30
SK28699A3 (en) 2000-03-13
NZ334274A (en) 2001-02-23
CN1680419A (zh) 2005-10-12
KR20050044816A (ko) 2005-05-12
ID19406A (id) 1998-07-09
RU2192427C2 (ru) 2002-11-10
ATE296308T1 (de) 2005-06-15
US6028181A (en) 2000-02-22
HRP20060276B1 (hr) 2014-04-25
DE69733439D1 (de) 2005-07-07
PT1291352E (pt) 2005-09-30
CN1680418A (zh) 2005-10-12
JP2001500855A (ja) 2001-01-23
SI20023B (en) 2001-02-28
ATE296831T1 (de) 2005-06-15
EP1291353B1 (de) 2005-06-01
BG63547B1 (bg) 2002-04-30
DE69733370D1 (de) 2005-06-30
SK285533B6 (sk) 2007-03-01
DE69733370T2 (de) 2006-02-02
ES2242812T3 (es) 2005-11-16
ATE299508T1 (de) 2005-07-15
ES2242983T3 (es) 2005-11-16
HRP20060277A2 (en) 2007-10-31
KR100576988B1 (ko) 2006-05-10
HRP20060275B1 (hr) 2014-04-11
SK285534B6 (sk) 2007-03-01
NO991022L (no) 1999-05-03
BR9711661A (pt) 1999-08-24
NO991022D0 (no) 1999-03-02
DK0929563T3 (da) 2005-10-03
SI20023A (sl) 2000-02-29
KR20050043993A (ko) 2005-05-11
ATE296307T1 (de) 2005-06-15
PT1291350E (pt) 2005-09-30
EP1291352A1 (de) 2003-03-12
EP1291351B1 (de) 2005-07-13
HRP20060277B1 (hr) 2014-04-11
HRP970473A2 (en) 1998-08-31
PT1291351E (pt) 2005-11-30
ES2242813T3 (es) 2005-11-16
DK1291350T3 (da) 2005-09-26
EP1291350A1 (de) 2003-03-12
HRP20060278A2 (en) 2007-10-31
HRP20060278B1 (hr) 2014-04-11
KR100568455B1 (ko) 2006-04-07
CZ68599A3 (cs) 1999-08-11
ES2242811T3 (es) 2005-11-16
USRE39591E1 (en) 2007-04-24
DK1291351T3 (da) 2005-10-24
HUP9902869A3 (en) 2001-04-28
KR100523679B1 (ko) 2005-10-26
PT929563E (pt) 2005-10-31
DE69733422D1 (de) 2005-07-07
SK285536B6 (sk) 2007-03-01
ATE296832T1 (de) 2005-06-15
AU4178097A (en) 1998-03-26
EP1291351A1 (de) 2003-03-12
KR20050044815A (ko) 2005-05-12
CZ300106B6 (cs) 2009-02-11
DE69733439T2 (de) 2006-05-04
DE69733723T2 (de) 2006-04-20
DE69733369T2 (de) 2006-01-26
HRP20060275A2 (en) 2007-10-31
PT1291353E (pt) 2005-10-31
TR199901127T2 (xx) 1999-07-21
EP1291350B1 (de) 2005-05-25
DE69733723D1 (de) 2005-08-18
EP1291352B1 (de) 2005-05-25
CA2263972A1 (en) 1998-03-12
IL128681A0 (en) 2000-01-31
KR20000068435A (ko) 2000-11-25
CN100441591C (zh) 2008-12-10
RO121473B1 (ro) 2007-06-29
EP0929563B1 (de) 2005-06-01
CA2263972C (en) 2008-01-29
DK1291352T3 (da) 2005-09-19
CN1273475C (zh) 2006-09-06
WO1998009978A1 (en) 1998-03-12
AU729348B2 (en) 2001-02-01
DK1291353T3 (da) 2005-10-03
SK286181B6 (sk) 2008-04-07
SK285535B6 (sk) 2007-03-01
EP1291353A1 (de) 2003-03-12
CN1680420A (zh) 2005-10-12
HRP20060276A2 (en) 2007-10-31
KR20050043994A (ko) 2005-05-11
HUP9902869A2 (hu) 2000-02-28
ES2244716T3 (es) 2005-12-16
US6075133A (en) 2000-06-13
EP0929563A1 (de) 1999-07-21
US6147197A (en) 2000-11-14
DE69733422T2 (de) 2006-05-04
CN1237183A (zh) 1999-12-01
HU230166B1 (hu) 2015-09-28
PL188173B1 (pl) 2004-12-31
CN100460415C (zh) 2009-02-11
HK1021537A1 (en) 2000-06-16
KR100610043B1 (ko) 2006-08-08
PL332009A1 (en) 1999-08-16

Similar Documents

Publication Publication Date Title
HRP970473B1 (en) 6-0-substituted ketolides having antibacterial activity
HUP9901086A2 (hu) Aril-szulfonil-amino-benzol-származékok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk gyógyászati készítmények előállítására
DE69330776D1 (de) Polymergebundene Paclitaxel-derivate
DE69416306T2 (de) Sphingoglycolipid und verwendung davon
AR012032A1 (es) Compuestos derivados 3'-n-oxido, 3'-n-dimetilamina, 9-oxima eritromicina a y un proceso para su preparacion
CA2173150A1 (en) Novel peptide derivatives
Bottalico et al. Cytochalasins: structure-activity relationships
AR015994A1 (es) Derivados de cetolidos 2-halo-6-o-sustituidos, composiciones farmaceuticas que los contienen, su uso para la manufactura de un medicamento y procesos parasu preparacion
TR199700974T1 (en) Fucopeptides.
FI923170A (fi) Spicamycinderivat och anvaendning av dem
DE69132580T2 (de) 7-Acyl-3-(substituierte carbamoyloxy) Cephem Verbindungen, Verfahren zu ihrer Herstellung und Anwendung
GB1530643A (en) Aminoglycosides
CO4960636A1 (es) Derivados de eritromicina 3-descladinosa 6-0-substituidos
IE41221L (en) Pyrazinemethanols
NZ334980A (en) Aminomethylene derivatives with ultraviolet absorption capability
GB1418399A (en) Antibiotic derivatives
GB1153304A (en) Thiodicarboxylic Esters and their use in Poly-alpha-Olefin Compositions
AU2953697A (en) Vitamin d analogs and methods of preparing these compounds
IE822725L (en) Azino methyl-rifamycins
ES8502700A1 (es) Procedimiento para la fabricacion de derivados de tetrahidrobenzotiazol.
GB2321459A (en) Synthesis of carboxylic acid derivatives
ATE196910T1 (de) 7-glykosyloxybenzopyranderivat und dieses enthaltendes antiallergisches mittel
NO922608L (no) Nye cefalosporinforbindelser og fremgangsmaater til deres fremstillin
ATE157985T1 (de) Antiparasitisches mittel
DK0384890T3 (da) Middel til beskyttelse af planter mod sygdomme

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
PPPP Transfer of rights

Owner name: ABBVIE INC., US

ODRP Renewal fee for the maintenance of a patent

Payment date: 20160901

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20170903